Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Venture Capital
Founders Philippe Gire Xavier Lazarus


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 151
Average round size
The average size of a deal this fund participated in
Portfolio companies 105
Rounds per year 7.55
Lead investments 43
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 25
Key employees 14
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Software
  • Information Technology
  • SaaS
  • Internet
  • Artificial Intelligence

Elaia is the famous VC, which was founded in 2002. The leading representative office of defined VC is situated in the Paris. The fund was located in Europe if to be more exact in France.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Big Data. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Criteo, NTRglobal, Ornikar. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Elaia, startups are often financed by Wilco, AGORANOV, Partech. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Kima Ventures, Iris Capital. In the next rounds fund is usually obtained by Partech, Bpifrance, Intel Capital.

Speaking about the real fund results, this VC is 8 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019. The usual things for fund are deals in the range of 5 - 10 millions dollars. Opposing the other organizations, this Elaia works on 4 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2017.

This organization was formed by Philippe Gire, Xavier Lazarus. Besides them, we counted 11 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Elaia:
Typical Co-investors
Elaia is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Elaia:

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Artificial Intelligence
Health Care
$23M21 Jun 2022 Leuven, Flemish Brabant, Belgium


Big Data
Cyber Security
Data Mining
$4M20 Jun 2022 Paris, Ile-de-France, France


Information Technology
$1M21 Apr 2022 -


$5M20 Apr 2022 Barcelona, Catalonia, Spain


$1M15 Apr 2022 New York, New York, United States

Alice & Bob

Information Services
Information Technology
$31M10 Mar 2022 Paris, Ile-de-France, France


Financial Services
$38M09 Feb 2022 Paris, Ile-de-France, France


Service Industry
$9M27 Jan 2022 Paris, Ile-de-France, France


Big Data
Health Care
$23M24 Jan 2022 France, Auvergne-Rhône-Alpes, France
Cryptosense Raises $4.8M in Funding

– Cryptosense, a Paris, France-based cryptography lifecycle management platform, raised $4.8m in funding.
– The round was led by Amadeus Capital Partners with participation from BGV and Elaia Partners.
– The company intends to use the funds to hire senior-level staff across the product and engineering teams, develop its partner program, and further expand operations across the U.S.

Mablink Bioscience Raises €4M in Seed Funding

– Mablink Bioscience is a Lyon, France-based company developing antibody-drug conjugates (ADC).
– The company raised €4M in a seed financing round.
Elaia Partners led the round with participation from Pertinence Invest 2 (Sofimac Innovation advised by Mérieux Equity Partners), Sham Innovation Santé (advised by Turenne Capital), Fondation Fournier-Majoie, Simba Santé (Angelor) and Crédit Agricole Création.
– The new investment will be used to move forward its ADC pipeline.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Elaia?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: